// App-Quantinova.ai

259 : Changing trends in TNF inhibitor prescribing for axial spondyloarthritis: the influence of National Institute for Health and Care Excellence guidance

Researchers

Presenter

  • Kit Yee Wong

Principal Investigators

  • Max Yates

  • Chong Seng Edwin Lim

  • Karl Gaffney

Medical Centers

  • East Norfolk Sixth Form College, East Norfolk Sixth Form College, Gorleston-on-Sea, UNITED KINGDOM

  • Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK

  • Department of Rheumatology, The Royal Free, London, UNITED KINGDOM

  • Rheumatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Ankylosing spondylitis

  • Spondyloarthritis

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • TA-383

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved